Drug Shortage Report for SOFRACORT

Last updated on 2022-08-16 History
Report ID 159765
Drug Identification Number 02224623
Brand name SOFRACORT
Common or Proper name Framycetin sulphate, Dexamethasone and Gramicidin Ophthalmic/Otic Solution
Company Name SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s) GRAMICIDIN DEXAMETHASONE FRAMYCETIN SULFATE
Strength(s) 0.05MG 0.5MG 5MG
Dosage form(s) DROPS
Route of administration OTIC OPHTHALMIC OTIC OPHTHALMIC
Packaging size 8 mL bottle
ATC code S03CA
ATC description CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2022-04-29
Estimated end date 2022-09-07
Actual end date 2022-08-15
Shortage status Resolved
Updated date 2022-08-16
Company comments Supply delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.
Health Canada comments
Tier 3 Status No
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2022-08-16 English Compare
v12 2022-08-15 French Compare
v11 2022-08-15 English Compare
v10 2022-06-09 French Compare
v9 2022-06-09 English Compare
v8 2022-05-03 French Compare
v7 2022-05-03 English Compare
v6 2022-05-03 English Compare
v5 2022-04-30 English Compare
v4 2022-04-29 French Compare
v3 2022-04-29 English Compare
v2 2022-04-29 French Compare
v1 2022-04-29 English Compare

Showing 1 to 13 of 13